Abstract
Based on experience with comprehensive patient involvement, we present data from implementation of portable, programmable infusion pumps (PPP) for home-based chemotherapy administration in patients with acute leukaemia and in lymphoma patients receiving (carmustine, etoposide, cytarabine, melphalan) BEAM regimen. Data from 84 patients, receiving 177 cycles of PPP administered chemotherapy, showed convincing safety with minor equipment errors encountered and with high patient satisfaction. In-hospital days could be reduced with 52% out of a total of 1197 treatment days. Homebased PPP has several advantages from a patient perspective and furthermore frees up in-hospital beds for patients in need of them.
Original language | English |
---|---|
Journal | British Journal of Haematology |
Volume | 181 |
Issue number | 5 |
Pages (from-to) | 637-641 |
Number of pages | 5 |
ISSN | 0007-1048 |
DOIs | |
Publication status | Published - 2018 |